Category: News

Historically high unemployment rates created by the “great virus crisis” of 2020 are tipped to be a boom for the mining industry, according to Gleneagle Securities’ Greg Tolpigin.

The United States government’s push to decarbonise the country’s power grid is expected to turbo-charge Australian uranium stocks, according to industry insiders.

When JVC launched VHS videos in 1971, it started a consumer revolution that permanently altered the way the public consume media. 

Commodity-related companies are tipped to do very well  in 2021 as governments around the world invest into infrastructure projects to stimulate the economy, according to Gleneagle Securities’ Gregory Tolpigin.

Internet users can expect to see changes in the way advertisements are served to them after Facebook’s attempt to ban news sites drove a massive consumer backlash.

In 1958, a forward-thinking design team at Ford Motors unveiled a revolutionary ‘Nucleon’ concept model – the world’s first and only nuclear car.

Emyria Limited (ASX: EMD) is an Australian drug development company that focuses on novel treatments for patients with unmet medical needs. The drug development programs are backed by proprietary clinical evidence, which is then used to inform future programs.

While most companies have now adopted cloud, the shift has not been seamless. A high percentage of global organisations are still yet to fully adopt cloud, due to their ongoing reliance on incompatible legacy equipment. 

Prestige British car maker Jaguar is pivoting away from traditional combustion engines under a new plan which will see the company go fully electric by 2025.

The past year has seen green energy indices drastically outperform general markets while their more traditional peers have dragged, due to the current easing demand and growing consumer concern for climate change

Australians have not responded well to Google’s threat to remove its search function from the country in response to a proposed media bargaining code, research shows.

The burgeoning CAR T therapy industry has passed another significant milestone after the US Food and Drug Administration (FDA) approved Breyanzi for use in certain blood cancers called B-cell lymphomas.